表紙
市場調査レポート

世界のポイントオブケア(POC)血液凝固検査市場の新たなフロンティア:ビジネス上の課題、新規技術、競争環境

POC/Point-of-Care Coagulation Testing Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

発行 Venture Planning Group 商品コード 304986
出版日 ページ情報 英文 450 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。

Local License: 同一事業所内

Back to Top
世界のポイントオブケア(POC)血液凝固検査市場の新たなフロンティア:ビジネス上の課題、新規技術、競争環境 POC/Point-of-Care Coagulation Testing Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape
出版日: ページ情報: 英文 450 Pages
概要

当レポートでは、世界の主要国(米国・ドイツ・スペイン)におけるポイントオブケア(POC)向け血液凝固検査関連の市場の現状・将来展望について分析し、関連技術および市場(検査試薬・試薬など)の最新状況や、国別・部門別の市場規模および成長率(今後5年間分)、規制環境、競争構造、今後の需要・技術活用方法の方向性、主要企業のプロファイルなどを調査しております。

イントロダクション

エグゼクティブ・サマリー

分散型検査製品の合理的根拠

世界の技術・市場の概況

  • イントロダクション
  • APTT(活性化部分トロンボプラスチン時間)
  • α2抗プラズミン物質
  • 抗トロンビンIII
  • 出血時間
  • D-ダイマー
  • 第III因子
  • フィブリン分解物
  • フィブリノゲン(線維素原)
  • ヘパリン
  • プロテインC&S
  • プロトロンビン時間(PT)
  • トロンビン時間

凝固検査用解析装置(全12社分)

現在・将来の技術

  • モノクローナル抗体
  • 疫学的検定
  • ドライケミストリー
  • バイオセンサー
  • IT・自動化
  • 分子診断

米国市場

  • 市場概況
    • ビジネス環境
    • 市場構造
  • 開業医・グループ診断
  • 補助的医療施設
  • がんクリニック
  • 外来治療センター
  • 外科手術センター
  • 介護施設
  • 産院
  • 主要サプライヤーの売上高・市場シェア

ドイツ市場

  • ビジネス環境
  • 市場構造
  • 市場概況
  • 検査件数・売上高予測
  • 主要サプライヤーの売上高・市場シェア

スペイン市場

  • ビジネス環境
  • 市場構造
  • 市場概況
  • 検査件数・売上高予測
  • 主要サプライヤーの売上高・市場シェア

主要製品の開発機会

  • ルーチン・特殊化学検査
  • 微生物/感染症検査
  • 血液検査・フローサイトメトリー
  • 血液凝固検査

分散型検査製品の設計基準

代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 技術の限界
  • 特許保護
  • 規制による抑制
  • 分散検査市場の課題

競合企業プロファイル

  • Abbott
  • ADI/American Diagnostica
  • Axis-Shield
  • Alere/Biosite/Inverness
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data Corporation
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago/Trinity Biotech
  • Grifols
  • Helena Laboratories
  • Hyphen BioMed
  • Instrumentation Laboratory
  • ITC/Nexus Dx
  • Roche
  • Siemens
  • Sienco
  • シスメックス
  • Thermo Fisher
  • ZyCare/Alere

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPPOC19993

VPGMarketResearch’s new report provides comprehensive analysis of the POC coagulation testing market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation

- Review of the POC coagulation market segment, including their dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for coagulation procedures by market segment:
Physician Offices/Group Practices Emergency Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Technology Review

- Emerging technologies and their applications for POC testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years. Design criteria for POC testing products. Alternative business expansion strategies. Potential market entry barriers and risks.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott    - ADI/American Diagnostica    - Agilent Technologies    - Alere/Biosite/Inverness    - Axis-Shield    - Beckman Coulter/Danaher    - Becton Dickinson    - Bio/Data    - Biomerieux    - Bio-Rad    - Cepheid    - Chrono-Log    - Corgenix    - Decode Genetics    - Diadexus    - Diagnocure    - Diagnostica Stago/Trinity Biotech    - Diamedix/Erba    - Diasorin    - Eiken Chemical    - EKF Diagnostics    - Fujirebio    - Grifols    - Helena Laboratories    - Hologic/Gen-Probe    - Horiba    - Instrumentation Laboratory    - International Technidyne/Nexus DX    - Kreatech/Leica    - Kyowa Medex    - Lonza    - Mackay Life Sciences    - Matritech    - Nihon Kohden    - Ortho-Clinical Diagnostics    - Polartechnics    - Polymedco    - Qiagen    - Roche    - SDIX    - Sequenom    - Siemens    - Sienco    - Sysmex    - Takara Bio    - Thermo Fisher    - Tosoh    - Wako    - Zycare/Alere

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contains 450 pages and 53 tables

Table of Contents

Introduction

Executive Summary

Rationale for Testing Decentralization

  • 1. Overview
  • 2. Regulatory Trends
  • 3. Economic Trends
  • 4. Demographic Trends
  • 5. Technological Trends
  • 6. Social Trends
  • 7. Quality of Care
  • 8. Defensive Medicine
  • 9. Quality Control Issues

Worldwide Market and Technology Overview

  • 1. Introduction
  • 2. Activated Partial Thromboplastin Time (APTT)
  • 3. Alpha-2 Antiplasmin
  • 4. Antithrombin III
  • 5. Bleeding Time
  • 6. D-Dimer
  • 7. Factor VIII
  • 8. Fibrin Degradation Products
  • 9. Fibrinogen
  • 10. Heparin
  • 11. Proteins C and S
  • 12. Prothrombin Time (PT)
  • 13. Thrombin Time

Instrumentation: Coagulation Analyzers Manufactured by:

  • Behnk Elektronik
  • Bio/Data
  • Cardiovascular Diagnostics
  • Diagnostica Stago
  • Helena Laboratories
  • Instrumentation Laboratory
  • ITC Hemochron
  • Roche
  • Siemens
  • Sysmex
  • Teco Medical Instruments
  • Trinity Biotech

Current and Emerging Technologies

  • 1. Monoclonal Antibodies
  • 2. Immunoassays
    • a. Technological Principle
    • b. Enzyme Immunoassays (EIA)
      • Overview
      • ELISA
      • Dot Immunobinding Assays
      • Capillary Immunoassays
      • Particle-Membrane Capture Immunoassay
      • Enzyme Amplification
    • c. Fluorescent Immunoassays
      • Fluorescent Polarization
      • Time-Resolved Pulse Fluorescence
    • d. Luminescence
      • Chemiluminescence
      • Bioluminescence
    • e. Latex Agglutination
    • f. Immunoprecipitation
  • 3. Dry Chemistry
  • 4. Biosensors
  • 5. IT and Automation
  • 6. Molecular Diagnostics
    • a. Technology Overview
    • b. Amplification Methods
      • Polymerase Chain Reaction
      • Ligase Chain Reaction
      • Branched DNA
      • Q-Beta Replicase
      • Strand Displacement Activation
      • Self-Sustained Sequence Replicase

U.S.A.

A. Market Overview

  • 1. Business Environment
    • a. Health Care Expenditures
    • b. Cost Consciousness
    • c. Reimbursement
    • d. Industry Consolidation
    • e. Managed Care
      • PPO
      • HMO
    • f. Hospitals
    • g. Admissions
    • h. Length of Stay
    • i. Industry Diversification
    • j. Physician Demographics
    • k. Aging Population
      • More Chronic Illness
      • Disease Incidence
      • Susceptibility to latrogenesis
      • Multiple Illnesses Cases
    • l. Laboratory Regulations
  • 2. Market Structure
    • a. Hospitals
    • b. Commercial/Private Laboratories

B. Physician Offices/Group Practices

  • 1. Market Summary
  • 2. Market Structure
  • 3. Test Volume and Sales Forecasts

C. Ancillary Hospital Locations

  • 1. Introduction
    • a. Emergency Departments
    • b. Operating Suites
    • c. Intensive Care Units
  • 2. Emergency Departments
    • a. Market Summary
    • b. Test volume and Sales Forecasts
  • 3. Operating and Recovery Suites
    • a. Market Summary
    • b. Test Volume and Sales Forecasts
  • 4. ICUs/CCUs
    • a. Market Summary
    • b. Test Volume and Sales Forecasts

D. Cancer Clinics

  • 1. Introduction
  • 2. Market Summary
  • 3. Test Volume and Sales Forecasts

E. Ambulatory Care Centers

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

F. Surgery Centers

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

G. Nursing Homes

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

H. Birth Centers

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

I. Major Suppliers' Instrument Placements, Installed Base, Consumables Sales and Market Shares

Germany

  • A. Market Overview
  • B. Market Structure
  • C. Market Summary
  • D. Test Volume and Sales Forecasts
  • E. Major Suppliers' Instrument Placements, Installed Base, Consumables Sales and Market Shares

Spain

  • A. Business Environment
  • B. Market Structure
  • C. Market Summary
  • D. Test Volume and Sales Forecasts
  • E. Major Suppliers' Instrument Placements,

Installed Base, Consumables Sales and Market Shares

Major Product Development Opportunities

  • A. Routine and Special Chemistry
  • B. Microbiology/Infectious Diseases
  • C. Hematology and Flow Cytometry
  • D. Coagulation

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
  • 1. Marketing Approaches
  • 2. Product complexity
  • 3. Customer Preference
  • 4. Established Suppliers
  • 5. Emerging Suppliers
  • 6. Major Types of Distributors
  • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Company Profile

  • Abbott
  • ADI/American Diagnostica
  • Axis-Shield
  • Alere/Biosite/Inverness
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data Corporation
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago/Trinity Biotech
  • Grifols
  • Helena Laboratories
  • Hyphen BioMed
  • Instrumentation Laboratory
  • ITC/Nexus Dx
  • Roche
  • Siemens
  • Sienco
  • Sysmex
  • Thermo Fisher
  • ZyCare/Alere

List of Tables

  • Major Companies Developing or Marketing APTT Tests
  • Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
  • Major Companies Developing or Marketing Antithrombin III Tests
  • Major Companies Developing or Marketing Bleeding Time Tests
  • Major Companies Developing or Marketing D-Dimer Tests
  • Major Companies Developing or Marketing Factor Assays Tests
  • Major Companies Developing or Marketing Fibrin Degradation Product Tests
  • Major Companies Developing or Marketing Fibrinogen Tests
  • Major Companies Developing or Marketing Heparin Tests
  • Major Companies Developing or Marketing Protein C Tests
  • Major Companies Developing or Marketing Protein S Tests
  • Major Companies Developing or Marketing PT Tests
  • Major Companies Developing or Marketing Thrombin Time Tests
  • U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
  • U.S.A., Physician Offices/Group Practices Forecast by Type
  • U.S.A., Office-Based Physicians Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Coagulation Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Ancillary Hospital Locations Estimated Number
  • U.S.A., Ancillary Hospital Locations Annual Utilization
  • U.S.A., Hospital Emergency Departments Coagulation Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Hospital Operating and Recovery Suites Coagulation Test Volume Forecast
  • U.S.A., Hospital Operating and Recovery Suites Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Hospital ICUs/CCUs Coagulation Test Volume Forecast
  • U.S.A., Hospital ICUs/CCUs Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Cancer Clinics Major Coagulation Test Volume Forecast
  • U.S.A., Cancer Clinics Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
  • U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
  • U.S.A., Ambulatory Care Centers Coagulation Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Surgery Centers Most Frequently Performed Procedures
  • U.S.A., Surgery Centers Coagulation Test Volume Forecast
  • U.S.A., Surgery Centers Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
  • U.S.A., Nursing Homes Coagulation Test Volume Forecast
  • U.S.A., Nursing Homes Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Birth Centers Facilities, Patient Visits, and Births
  • U.S.A., Birth Centers Coagulation Test Volume Forecast
  • U.S.A., Birth Centers Coagulation Reagent and Instrument Sales Forecast
  • U.S.A., Major Suppliers of Coagulation Diagnostic Products Estimated Market Shares
  • Germany, Laboratory Performing Diagnostic Tests by Market Segment
  • Germany, Physician Offices/Group Practices Coagulation Test Volume Forecast
  • Germany, Physician Offices/Group Practices Coagulation Reagent and Instrument Sales Forecast
  • Germany, Major Suppliers of Coagulation Diagnostic Products Estimated Market Shares
  • Spain, Laboratory Performing Coagulation Tests by Market Segment
  • Spain, Ambulatory Care Centers Coagulation Test Volume Forecast
  • Spain, Ambulatory Care Centers Coagulation Reagent and Instrument Sales Forecast
  • Spain, Major Suppliers of Coagulation Diagnostic Products Estimated Market Shares
Back to Top